机构:[1]Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China四川大学华西医院[2]Department of Biochemistry & Molecular Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, 610041, China[3]Institute of Urology, Department of Urology, West China Hospital, Sichuan University, 610041, Chengdu, China四川大学华西医院
the National Natural Science
Foundation of China (Grant Nos. 81771812 and
81571637), the Sichuan Science and Technology Program
(2018SZ0391 and 2016HH0065).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|3 区医学
小类|3 区药物化学
最新[2023]版:
大类|4 区医学
小类|4 区药物化学
第一作者:
第一作者机构:[1]Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Nuclear Medicine, West China Hospital, Sichuan University, 610041, Chengdu, China[*1]Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, Sichuan 610041, P.R. China
推荐引用方式(GB/T 7714):
Diao Wei,Cai Huawei,Chen Lihong,et al.Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals.[J].Current topics in medicinal chemistry.2019,19(1):33-56.doi:10.2174/1568026619666190201100739.
APA:
Diao Wei,Cai Huawei,Chen Lihong,Jin Xi,Liao Xinyang&Jia Zhiyun.(2019).Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals..Current topics in medicinal chemistry,19,(1)
MLA:
Diao Wei,et al."Recent Advances in Prostate-Specific Membrane Antigen-Based Radiopharmaceuticals.".Current topics in medicinal chemistry 19..1(2019):33-56